ReviewThe oncologist2021

Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines.

Mario E Lacouture et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.